Unknown

Dataset Information

0

A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.


ABSTRACT:

Background

Neonatal enterovirus sepsis has high mortality. Antiviral therapy is not available.

Methods

Neonates with suspected enterovirus sepsis (hepatitis, coagulopathy, and/or myocarditis) with onset at ≤15 days of life were randomized 2:1 to receive oral pleconaril or placebo for 7 days. Serial virologic (oropharynx, rectum, urine, serum), clinical, pharmacokinetic, and safety evaluations were performed.

Results

Sixty-one subjects were enrolled (43 treatment, 18 placebo), of whom 43 were confirmed enterovirus infected (31 treatment, 12 placebo). There was no difference in day 5 oropharyngeal culture positivity (primary endpoint; 0% in both groups). However, enterovirus-infected subjects in the treatment group became culture negative from all anatomic sites combined faster than placebo group subjects (median 4.0 versus 7.0 days, P = .08), and fewer subjects in the treatment group remained polymerase chain reaction (PCR)-positive from the oropharynx when last sampled (23% versus 58%, P = .02; median, 14.0 days). By intent to treat, 10/43 (23%) subjects in the treatment group and 8/18 (44%) in the placebo group died (P = .02 for 2-month survival difference); among enterovirus-confirmed subjects, 7/31 (23%) in the treatment group died versus 5/12 (42%) in the placebo group (P = .26). All pleconaril recipients attained concentrations greater than the IC90 after the first study day, but 38% were less than the IC90 during the first day of treatment. One subject in the treatment group and three in the placebo group had treatment-related adverse events.

Conclusions

Shorter times to culture and PCR negativity and greater survival among pleconaril recipients support potential efficacy and warrant further evaluation.

SUBMITTER: Abzug MJ 

PROVIDER: S-EPMC4765488 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2016-07-15 | E-GEOD-76003 | biostudies-arrayexpress
| S-EPMC4077042 | biostudies-other
2016-07-15 | GSE76003 | GEO
| S-EPMC7431947 | biostudies-literature
2017-02-09 | GSE74988 | GEO
| S-EPMC5947135 | biostudies-other
2024-07-10 | MSV000095296 | MassIVE
| S-EPMC6415909 | biostudies-literature
2023-06-30 | GSE209696 | GEO
2018-04-25 | GSE84453 | GEO